The both the groups of T2DM with CAD patients shown significantly elevated levels of interleukin 6,based on this findings interleukin 6 might be used as early predictable and prognostic marker for CAD in patients with T2DM. The gene discussed is IL6; the disease is type 2 diabetes mellitus.